logo

Incannex Healthcare Limited (IXHL)



Trade IXHL now with
  Date
  Headline
7/21/2022 7:56:38 AM Incannex Gets Ethics Approval To Commence Phase 1 Trial Of Multi-Use Anti-Inflammatory Drug IHL-675A
6/3/2022 7:58:31 AM Incannex Announces Positive Results From Phase 2 Trial Of IHL-42X For Treatment Of Obstructive Sleep Apnoea
5/17/2022 7:58:03 AM Incannex Announces Positive Pre-IND Meeting With FDA For IHL-42X For Obstructive Sleep Apnoea
3/24/2022 7:58:52 AM Incannex Agrees To Acquire APIRx Pharmaceuticals USA, LLC